| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |